Fig. 8.
Fig. 8. Neutrophil and monocyte activation by the TLR2 ligand, araLAM, is enhanced by GM-CSF treatment. / (A) GM-CSF enhances araLAM-stimulated IL-8 secretion from both neutrophils and monocytes. Neutrophils and monocytes were incubated with or without GM-CSF (1-100 U/mL) and stimulated with (○) araLAM (1 μg/mL) or (▪) medium alone. IL-8 secretion was measured 18 hours later by ELISA. (B) araLAM stimulates TLR2-expressing cells but not TLR4-expressing cells. HEK293 clones expressing TLR2, TLR4, or no TLR (none) were incubated with (▪) araLAM (1 μg/mL), (░) phenol-extracted LPS (10 ng/mL), or (■) medium alone. Secretion of IL-8 was measured 18 hours later by ELISA.

Neutrophil and monocyte activation by the TLR2 ligand, araLAM, is enhanced by GM-CSF treatment.

(A) GM-CSF enhances araLAM-stimulated IL-8 secretion from both neutrophils and monocytes. Neutrophils and monocytes were incubated with or without GM-CSF (1-100 U/mL) and stimulated with (○) araLAM (1 μg/mL) or (▪) medium alone. IL-8 secretion was measured 18 hours later by ELISA. (B) araLAM stimulates TLR2-expressing cells but not TLR4-expressing cells. HEK293 clones expressing TLR2, TLR4, or no TLR (none) were incubated with (▪) araLAM (1 μg/mL), (░) phenol-extracted LPS (10 ng/mL), or (■) medium alone. Secretion of IL-8 was measured 18 hours later by ELISA.

Close Modal

or Create an Account

Close Modal
Close Modal